{
  "id": 17392461,
  "title": "Japan Performs World’s First Stem Cell Treatment for Parkinson’s Disease",
  "url": "https://urgent.news/2026/10/31/japan-performs-worlds-first-stem-cell-treatment-for-parkinsons-disease",
  "topic": "tech",
  "section": "Tech",
  "published": "2026-10-31T10:56:20.000Z",
  "source": {
    "name": "ProPakistani",
    "slug": "propakistani",
    "url": "https://propakistani.pk/2026/10/31/japan-performs-worlds-first-stem-cell-treatment-for-parkinsons-disease/"
  },
  "original_language": "en",
  "account": "In Japan, a groundbreaking stem-cell treatment for Parkinson's disease has been successfully carried out for the first time, according to Sumitomo Pharma. The therapy, which received conditional approval from Japanese regulators in March, involves transplanting millions of induced pluripotent stem cells into a patient's brain. These cells have the potential to develop into various types of cells, offering hope for treating neurological disorders. Parkinson's disease, a chronic and progressive neurological disorder, affects the body's motor system and is characterized by tremors, stiffness, and difficulties with movement. More than 10 million people worldwide live with the condition, and existing treatments primarily focus on symptom control rather than halting its progression. Sumitomo Pharma's innovative approach uses iPS cells derived from healthy donors, which are reprogrammed into precursor cells capable of producing dopamine. This is crucial as Parkinson's disease leads to the loss of dopamine-producing brain cells over time. In a clinical trial involving seven patients aged between 50 and 69, the experimental treatment was administered by implanting either five million or 10 million cells into both sides of each patient's brain. The participants were monitored for two years, and no major adverse effects were observed. Additionally, four of the seven patients experienced improvements in their symptoms. Sumitomo Pharma intends to conduct transplants on 20 to 30 patients by March 2029 and is also running a clinical trial of the treatment in the United States. If safety and effectiveness are confirmed, the therapy could receive full approval in Japan in the next seven years.",
  "summary": "A patient in Japan has received a pioneering stem-cell treatment for Parkinson’s disease, marking a world-first following the therapy’s conditional … Read More The post Japan Performs World’s First Stem Cell Treatment for Parkinson’s Disease appeared first on ProPakistani .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}